1. Home
  2. SYF vs VTRS Comparison

SYF vs VTRS Comparison

Compare SYF & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYF
  • VTRS
  • Stock Information
  • Founded
  • SYF 1932
  • VTRS 1961
  • Country
  • SYF United States
  • VTRS United States
  • Employees
  • SYF N/A
  • VTRS N/A
  • Industry
  • SYF Finance: Consumer Services
  • VTRS Medicinal Chemicals and Botanical Products
  • Sector
  • SYF Finance
  • VTRS Health Care
  • Exchange
  • SYF Nasdaq
  • VTRS Nasdaq
  • Market Cap
  • SYF 19.4B
  • VTRS 15.6B
  • IPO Year
  • SYF N/A
  • VTRS N/A
  • Fundamental
  • Price
  • SYF $67.75
  • VTRS $13.16
  • Analyst Decision
  • SYF Buy
  • VTRS Hold
  • Analyst Count
  • SYF 22
  • VTRS 3
  • Target Price
  • SYF $55.23
  • VTRS $13.33
  • AVG Volume (30 Days)
  • SYF 4.1M
  • VTRS 8.3M
  • Earning Date
  • SYF 01-21-2025
  • VTRS 11-07-2024
  • Dividend Yield
  • SYF 1.49%
  • VTRS 3.63%
  • EPS Growth
  • SYF 41.97
  • VTRS N/A
  • EPS
  • SYF 7.67
  • VTRS N/A
  • Revenue
  • SYF $9,007,000,000.00
  • VTRS $15,048,500,000.00
  • Revenue This Year
  • SYF N/A
  • VTRS N/A
  • Revenue Next Year
  • SYF $1.63
  • VTRS N/A
  • P/E Ratio
  • SYF $8.81
  • VTRS N/A
  • Revenue Growth
  • SYF 16.99
  • VTRS N/A
  • 52 Week Low
  • SYF $33.51
  • VTRS $9.31
  • 52 Week High
  • SYF $68.69
  • VTRS $13.62
  • Technical
  • Relative Strength Index (RSI)
  • SYF 71.38
  • VTRS 59.41
  • Support Level
  • SYF $66.64
  • VTRS $12.94
  • Resistance Level
  • SYF $68.69
  • VTRS $13.25
  • Average True Range (ATR)
  • SYF 1.36
  • VTRS 0.28
  • MACD
  • SYF -0.12
  • VTRS -0.03
  • Stochastic Oscillator
  • SYF 82.23
  • VTRS 56.86

About SYF Synchrony Financial

Synchrony Financial, originally a spinoff of GE Capital's retail financing business, is the largest provider of private-label credit cards in the United States by both outstanding receivables and purchasing volume. Synchrony partners with other firms to market its credit products in their physical stores as well as on their websites and mobile applications. Synchrony operates through three segments: retail card (private-label and co-branded general-purpose credit cards), payment solutions (promotional financing for large ticket purchases), and CareCredit (financing for elective healthcare procedures).

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: